Article,

Leukotriene B4 receptors on neutrophils in patients with psoriasis and atopic eczema

, , , and .
Skin Pharmacol, 2 (2): 61-7 (1989)Meier, F Gross, E Klotz, K N Ruzicka, T Comparative Study Research Support, Non-U.S. Gov't Switzerland Skin pharmacology : the official journal of the Skin Pharmacology Society Skin Pharmacol. 1989;2(2):61-7..

Abstract

Polymorphonuclear leukocyte (PMNL) infiltration is an important characteristic in psoriatic lesions. Elevated concentrations of the chemoattractant eicosanoid leukotriene B4 (LTB4) are present in psoriatic skin. Its chemotactic activity is mediated via high affinity receptors on PMNL. The goal of our work was to ascertain whether PMNL infiltration in psoriasis can be accounted for by functional abnormalities of the circulating PMNL due to alterations in the LTB4 receptor density or affinity (or both). No significant difference was found between patients with psoriasis, healthy controls and patients with another inflammatory dermatosis (atopic eczema) with regard to the binding parameters of LTB4 receptors on PMNL. Our findings suggest that PMNL accumulation in psoriatic skin may be the result of an excess of cutaneous chemoattractant rather than the increased readiness of psoriatic PMNL to migrate towards LTB4 due to altered LTB4 receptor density or affinity.

Tags

Users

  • @pharmawuerz

Comments and Reviews